News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Organ Recovery Biotech Angion Biomedica Corp. Files For A $35 Million IPO


4/15/2014 8:31:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Angion Biomedica, which develops a therapy for injured organs that triggers the body's natural regenerative process, filed on Monday with the SEC to raise up to $35 million in an initial public offering. Its lead candidate is designed to speed the recovery time for patients after a kidney transplant, but Angion believes it can be used to prevent and repair damage to other organs as well.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES